February 3, 2016

Merit Medical Acquires the Hero Graft From CryoLife

February 4, 2016—Merit Medical Systems, Inc. announced that it has purchased the Hero Graft device and related assets from CryoLife, Inc. for $18.5 million. The Hero Graft is a fully subcutaneous vascular access system that is intended for use in maintaining long-term vascular access for chronic hemodialysis patients who have exhausted peripheral venous access sites suitable for fistulas or grafts.

The Hero Graft device has 510(k) clearance from the US Food and Drug Administration and European CE Mark approval, stated Merit Medical.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

February 3, 2016

Merit Medical Acquires the Hero Graft From CryoLife

Current Issue

Keep In Touch